THE ACTIONS OF BOSENTAN, AN ENDOTHELIN RECEPTOR ANTAGONIST, ON CEREBRAL ARTERIOLES IN-SITU

被引：0
|
作者：
PATEL, TR [1 ]
MCAULEY, MA [1 ]
MCCULLOCH, J [1 ]
机构：
[1] UNIV GLASGOW,WELLCOME NEUROSCI GRP,GLASGOW G61 1QH,SCOTLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1994年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：U31 / U31
页数：1
相关论文
共 50 条
  • [21] No influence of the endothelin receptor antagonist bosentan on basal and indomethacin-induced reduction of cerebral blood flow in pigs
    Rasmussen, M
    Poulsen, PH
    Treiber, A
    Delahaye, S
    Tankisi, A
    Cold, GE
    Therkelsen, K
    Gjedde, A
    Astrup, J
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2003, 47 (02) : 200 - 207
  • [22] The pharmacology of endothelin and its antagonist bosentan
    Clozel, M
    Roux, S
    ANNALES D ENDOCRINOLOGIE, 2000, 61 (01) : 75 - 79
  • [23] Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?
    Ozdogan, O
    Goren, Z
    Tozun, N
    Moini, H
    Bilsel, S
    Celikel, C
    Kalayci, C
    Berkman, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1354 - A1354
  • [24] Effects of endothelin receptor inhibition on cerebral arterioles in hypertensive rats
    Chillon, JM
    Heistad, DD
    Baumbach, GL
    HYPERTENSION, 1996, 27 (03) : 794 - 798
  • [25] The dual endothelin receptor antagonist bosentan inhibits migration of human monocytes in vitro
    Desole, S.
    Vogelsinger, H.
    Cima, K.
    Kaehler, C. M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2007, 119 (17-18) : A16 - A16
  • [26] Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects
    Weber, C
    Schmitt, R
    Birnboeck, H
    Hopfgartner, G
    vanMarle, SP
    Peeters, PAM
    Jonkman, JHG
    Jones, CR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (02) : 124 - 137
  • [27] THE EFFECT OF THE ENDOTHELIN-1 DUAL RECEPTOR ANTAGONIST, BOSENTAN, ON PLATELET FUNCTION
    Wort, S. J.
    Davidson, S.
    Corte, T. J.
    Park, J.
    Harries, C.
    Gatzoulis, M.
    THORAX, 2008, 63 : A54 - A54
  • [28] Bosentan, a dual endothelin receptor antagonist, is a mild inducer of the metabolism of simvastatin.
    Dingemanse, J
    Schaarschmidt, D
    van Giersbergen, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P45 - P45
  • [29] Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis
    Nishibu, Akiko
    Sakai, Erika
    Oyama, Noritaka
    Yamamoto, Toshiyuki
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 (02) : E32 - E33
  • [30] Research and development of a second-generation process for bosentan, an endothelin receptor antagonist
    Harrington, PJ
    Khatri, HN
    DeHoff, BS
    Guinn, MR
    Boehler, MA
    Glaser, KA
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2002, 6 (02) : 120 - 124
12345